133 related articles for article (PubMed ID: 1332025)
1. Structural studies of the retroviral proteinase from avian myeloblastosis associated virus.
Ohlendorf DH; Foundling SI; Wendoloski JJ; Sedlacek J; Strop P; Salemme FR
Proteins; 1992 Nov; 14(3):382-91. PubMed ID: 1332025
[TBL] [Abstract][Full Text] [Related]
2. Specificity studies on retroviral proteinase from myeloblastosis-associated virus.
Strop P; Konvalinka J; Stys D; Pavlickova L; Blaha I; Velek J; Travnicek M; Kostka V; Sedlacek J
Biochemistry; 1991 Apr; 30(14):3437-43. PubMed ID: 1849425
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a retroviral protease proves relationship to aspartic protease family.
Miller M; Jaskólski M; Rao JK; Leis J; Wlodawer A
Nature; 1989 Feb; 337(6207):576-9. PubMed ID: 2536902
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.
Cameron CE; Grinde B; Jacques P; Jentoft J; Leis J; Wlodawer A; Weber IT
J Biol Chem; 1993 Jun; 268(16):11711-20. PubMed ID: 8389361
[TBL] [Abstract][Full Text] [Related]
5. High-resolution structure of the catalytic domain of avian sarcoma virus integrase.
Bujacz G; Jaskólski M; Alexandratos J; Wlodawer A; Merkel G; Katz RA; Skalka AM
J Mol Biol; 1995 Oct; 253(2):333-46. PubMed ID: 7563093
[TBL] [Abstract][Full Text] [Related]
6. Myeloblastosis associated virus (MAV) proteinase site-mutated to be HIV-like has a higher activity and allows production of infectious but morphologically altered virus.
Sedlacek J; Fabry M; Coward JE; Horejsi M; Strop P; Luftig RB
Virology; 1993 Feb; 192(2):667-72. PubMed ID: 7678476
[TBL] [Abstract][Full Text] [Related]
7. X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes.
Lapatto R; Blundell T; Hemmings A; Overington J; Wilderspin A; Wood S; Merson JR; Whittle PJ; Danley DE; Geoghegan KF
Nature; 1989 Nov; 342(6247):299-302. PubMed ID: 2682266
[TBL] [Abstract][Full Text] [Related]
8. Subsite specificity of the proteinase from myeloblastosis associated virus.
Konvalinka J; Blaha I; Skrabana R; Sedlacek J; Pichova I; Kapralek F; Kostka V; Strop P
FEBS Lett; 1991 Apr; 282(1):73-6. PubMed ID: 2026269
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of homology modeling of HIV protease.
Weber IT
Proteins; 1990; 7(2):172-84. PubMed ID: 2158092
[TBL] [Abstract][Full Text] [Related]
10. Processing, purification, and kinetic characterization of the Gag-Pol encoded retroviral proteinase of myeloblastosis associated virus expressed in E. coli.
Brynda J; Fábry M; Tichý PJ; Horejsí M; Sedlácek J
Adv Exp Med Biol; 1995; 362():485-8. PubMed ID: 8540362
[No Abstract] [Full Text] [Related]
11. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
Hrusková-Heidingsfeldová O; Bláha I; Urban J; Strop P; Pichová I
Leukemia; 1997 Apr; 11 Suppl 3():45-6. PubMed ID: 9209292
[TBL] [Abstract][Full Text] [Related]
12. 15gag proteinase of myeloblastosis-associated virus: specificity studies with substrate-based inhibitors.
Pavlícková L; Stys D; Soucek M; Urban J; Hrusková O; Sedlácek J; Strop P
Arch Biochem Biophys; 1992 Nov; 298(2):753-6. PubMed ID: 1417001
[TBL] [Abstract][Full Text] [Related]
13. Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases.
Rao JK; Erickson JW; Wlodawer A
Biochemistry; 1991 May; 30(19):4663-71. PubMed ID: 1851433
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
[TBL] [Abstract][Full Text] [Related]
15. Secondary structural analysis of retrovirus integrase: characterization by circular dichroism and empirical prediction methods.
Lin TH; Quinn TP; Grandgenett D; Walsh MT
Proteins; 1989; 5(2):156-65. PubMed ID: 2546146
[TBL] [Abstract][Full Text] [Related]
16. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
17. Alternative native flap conformation revealed by 2.3 A resolution structure of SIV proteinase.
Wilderspin AF; Sugrue RJ
J Mol Biol; 1994 May; 239(1):97-103. PubMed ID: 8196050
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor.
Katoh I; Yasunaga T; Ikawa Y; Yoshinaka Y
Nature; 1987 Oct 15-21; 329(6140):654-6. PubMed ID: 2821409
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases.
Wallin M; Deinum J; Goobar L; Danielson UH
J Gen Virol; 1990 Sep; 71 ( Pt 9)():1985-91. PubMed ID: 2212989
[TBL] [Abstract][Full Text] [Related]
20. p15gag proteinase of myeloblastosis associated virus: specificity studies with substrate based inhibitors.
Strop P; Pavlícková L; Stys D; Soucek M; Urban J; Hrusková O; Kaprálek F; Jecmen P; Sedlácek J; Kostka V
Adv Exp Med Biol; 1991; 306():519-23. PubMed ID: 1812752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
